CIK: 1535289 - Address: 2401 Elliott Avenue, Suite 320, Seattle, WA 98121
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
12/4/24 17:20
12/4/24
CATXPerspective Therapeutics, Inc.DEHealthMdEqSurgical & Medical InstrumentSpoor Johan M.WADOCEOP303.77081755D
11/26/24 07:00
11/25/24
CATXPerspective Therapeutics, Inc.DEHealthMdEqSurgical & Medical InstrumentSpoor Johan M.WADOCEOP1003.7902713234M
6/13/24 17:19
6/13/24
CATXPerspective Therapeutics, Inc.DEHealthMdEqSurgical & Medical InstrumentSpoor Johan M.WADOCEOP1171.17010093208D
1/2/19 18:47
12/28/18
AZRXAzurrx Biopharma, Inc.DEHealthDrugPharmaceutical PreparationsSpoor Johan M.NYDOP,CEOP501.3003911378D
1/8/14 16:30
1/7/14
FPMIFluoropharma Medical, Inc.NVHealthDiagnIn Vitro & In Vivo DiagnosticSpoor Johan M.NJDOCEO,P,CBP.d50.50000105200D
11/27/12 09:00
11/26/12
FPMIFluoropharma Medical, Inc.NVHealthDiagnIn Vitro & In Vivo DiagnosticSpoor Johan M.NJDOCEO,P,CBP80.75500106190D
9/12/12 13:19
9/12/12
FPMIFluoropharma Medical, Inc.NVHealthDiagnIn Vitro & In Vivo DiagnosticSpoor Johan M.NJDOCEO,P,CBP400.800005062130D
8/3/12 15:36
8/3/12
FPMIFluoropharma Medical, Inc.NVHealthDiagnIn Vitro & In Vivo DiagnosticSpoor Johan M.NJDOCEO,P,CFP40.840005780D
6/15/12 16:41
6/15/12
FPMIFluoropharma Medical, Inc.NVHealthDiagnIn Vitro & In Vivo DiagnosticSpoor Johan M.NJDOCEO,P,CFP50.820006975D
11/21/11 20:36
11/18/11
FPMIFluoropharma Medical, Inc.NVHealthDiagnIn Vitro & In Vivo DiagnosticSpoor Johan M.MAOCEOP51.0005774D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact